Aspirin

SAN DIEGO — Preventing the first thrombosis, and better circumvention of the second, are currently the biggest obstacles in managing antiphospholipid syndrome, according to a speaker at the 2024 Congress of Clinical Rheumatology West.

A genetics-based platelet reactivity score can help identify people with a hyperreactive platelet phenotype who may have increased risk for a cardiovascular event, according to research published in Nature Communications.

Abbott announced the FDA approved elimination of aspirin as part of routine management from the label of its fully magnetically levitated left ventricular assist device.

Apixaban and aspirin offered similar protection against major ischemic and hemorrhagic events among people with cancer history and cryptogenic stroke.

Patients with breast cancer who reported high burdens of pain and stress had poorer outcomes than those with lower pain or stress levels, according to research presented at ASCO Annual Meeting.

Patient sex had seemingly no effect on the safety and efficacy of aspirin for patients with atherosclerotic CVD, according to secondary analysis of the ADAPTABLE trial published in JAMA Cardiology.

Almost one-third of adults aged 60 years and older without CVD regularly used aspirin for primary prevention in 2021, contrary to guidance from medical organizations, a study showed.

Results from a large cohort study showed low-dose aspirin may be a safe and effective prophylaxis for the prevention of venous thromboembolism following total knee arthroplasty.

In an analysis of more than 3,100 older adults, low-dose aspirin administered for 3 years did not affect the incidence or progression of age-related macular degeneration, according to study results published in JAMA Ophthalmology.

BOSTON — Aspirin may not be as beneficial vs. other agents for primary CVD prevention following recent research, according to a speaker at the ACP Internal Medicine Meeting.